Premedication with sublingual or oral alprazolam in adults undergoing diagnostic upper gastrointestinal endoscopy
- 30 June 2014
- journal article
- research article
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 46 (08) , 633-639
Abstract
Background and study aim: Diagnostic esophagogastroduodenoscopy (EGD) is uncomfortable for most patients. We determined the efficacy of alprazolam, administered orally or sublingually, as premedication for sedation during EGD. Patients and methods: Adult EGD candidates were randomly allocated to four groups (n = 55, each group) and received alprazolam (0.5 mg) sublingually or orally, placebo sublingually or orally at 30 minutes before EGD. Main outcome measures included procedure-related anxiety and pain/discomfort (assessed using 11-point numeric scales), patient overall tolerance (assessed using a 4-point Likert scale), need for intravenous sedation, and willingness to repeat the EGD if necessary. Results: Patients experienced greater reduction in anxiety score after medication with sublingual alprazolam (mean 2.25, standard deviation [SD] 1.73) compared with sublingual placebo (mean 0.10, standard error [SE] 0.15]; P < 0.001) and oral alprazolam (0.63, SE 0.14; P < 0.001). Also, pain/discomfort scores were lower with sublingual alprazolam compared with sublingual placebo (3.29, SE 0.29 vs. 4.16, SD 1.86; P = 0.024), and with oral alprazolam compared with oral placebo (3.48, SD 1.69 vs. 5.13, SD 2.39; P < 0.001). Patient overall tolerance was better with sublingual alprazolam than with sublingual placebo (P = 0.005) or with oral alprazolam (P = 0.009). Regarding intravenous sedation, there was no difference between sublingual alprazolam and sublingual placebo (10.9 % vs. 10.9 %; P = 0.619) or between oral alprazolam and oral placebo (9.0 % vs. 12.7 %; P = 0.381). Willingness to repeat the procedure was greater with sublingual alprazolam than with sublingual placebo (50.9 % vs. 30.9 %; P = 0.026). Conclusions: Sublingual alprazolam is an effective premedication for sedation during EGD. It reduces anxiety and pain/discomfort related to EGD and increases patient tolerance and willingness to repeat the EGD if necessary. Clinical trial registration: NCT01949038 ClinicalTrials.govKeywords
This publication has 13 references indexed in Scilit:
- Studies Comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for Assessment of Pain Intensity in Adults: A Systematic Literature ReviewJournal of Pain and Symptom Management, 2011
- Oral Medication With Diazepam or Midazolam Associated or Not With Clonidine for Oculoplastic Office Surgery Under Local AnesthesiaOphthalmic Plastic & Reconstructive Surgery, 2010
- Use of oral midazolam in pediatric upper gastrointestinal endoscopyPediatrics International, 2010
- A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic proceduresGastrointestinal Endoscopy, 2008
- Premedication with orally administered lorazepam in adults undergoing ERCP: a randomized double-blind studyGastrointestinal Endoscopy, 2007
- AGA Institute Review of Endoscopic SedationGastroenterology, 2007
- The effect of an information brochure on patients undergoing gastrointestinal endoscopy: A randomized controlled studyPatient Education and Counseling, 2006
- The minimum clinically significant difference in patient-assigned numeric scores for painThe American Journal of Emergency Medicine, 2005
- Preoperative Alprazolam Reduces Anxiety in Ambulatory Surgery Patients: A Comparison with Oral MidazolamAnesthesia & Analgesia, 2002
- A Comparison of Oral Diazepam Versus Midazolam, Administered With Intravenous Meperidine, as Premedication to Sedation for Pediatric EndoscopyJournal of Pediatric Gastroenterology and Nutrition, 2002